Value of Absolute Eosinophil Count in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
DOI: https://doi.org/10.2147/ijgm.s451900
IF: 2.145
2024-03-18
International Journal of General Medicine
Abstract:Yufei Wang, 1, &ast Xiaoteng Ma, 1, &ast Zhiqiang Yang, 1, 2 Qiuxuan Li, 1 Yujie Zhou, 1, 3 Fei Gao, 1, 3 Zhijian Wang 1, 3 1 Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Ministry of Education, Beijing, People's Republic of China; 2 Cardio-Metabolic Medicine Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; 3 The Key Laboratory of Remodeling-Related Cardiovascular Disease, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhijian Wang; Fei Gao, Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, the Key Laboratory of Remodeling-related Cardiovascular Disease, Beijing Institute of Heart Lung and Blood Vessel Disease, Anzhen Avenue &num2, Chaoyang District, Beijing, 100029, People's Republic of China, Email ; Background and Aims: Elevated eosinophils typically indicate hypersensitive inflammation; however, their involvement in cardiovascular events remains incompletely understood. We investigated the association between the absolute eosinophil count (AEC) and major adverse cardiovascular and cerebrovascular events (MACCEs) in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). Additionally, we determine whether the integration of AEC with the SYNTAX II score could improve predictive ability. Methods and Results: The AECs of 1711 patients with ACS undergoing PCI from June 2016 to November 2017 were analyzed on admission. All recruitments were splitted into three groups based on AEC tertiles and 101 participants underwent one or more noteworthy outcomings. The association between AEC and MACCEs (defined as a composite of cardiovascular death, myocardial infarction [MI], and stroke) was tested by Cox proportional-hazards regression analysis. After adjusting for confounders, AEC was independently associated with MACCEs (HR 11.555, 95% CI: 3.318– 40.239). Patients in the lowest AEC tertile (T1) as a reference, those in the higher tertiles had an incrementally higher risk of MACCEs (T3: HR 1.848 95% CI: 1.157– 2.952; P for trend=0.008). Inclusion of AEC enhanced the predictive accuracy of the SYNTAX II score for MACCEs (AUC: from 0.701 [95% CI: 0.646– 0.756] to 0.728 [95% CI: 0.677– 0.780]; DeLong's test, P = 0.020). Conclusion: AEC is independently linked to MACCEs in ACS patients who underwent PCI, and adds incremental predictive information to the SYNTAX II score. Keywords: absolute eosinophil count, SYNTAX I score, SYNTAX II score, cardiovascular and cerebrovascular events, acute coronary syndrome, percutaneous coronary intervention Coronary artery disease (CAD), a major contributor to the overall burden of death in the human population, related to pathological process of atherosclerosis, is mainly elucidated as a series of heart disease caused by myocardial ischemia, hypoxia, or necrosis. 1 The formation and advancement of atherosclerosis is closely connected to inflammation. Many previous contributions have shown that the inflammation is closely bound with the development of coronary atherosclerosis, and is the key characteristic of atherosclerosis and its clinical signs. Therefore, it is necessary to monitor inflammatory markers. However, new biomarkers of inflammation are needed to boost the diagnostic precision and provide prognostic insights into atherosclerosis. White blood cell (WBC) count is a widely used inflammatory marker in the clinical practice, which has been demonstrated to be an autonomous risk factor of MI, unstable angina, and stable CAD with a history of MI. 2,3 As we know, white blood cells include lymphocytes, neutrophils, monocytes and eosinophils. The study of Zhao et al 4 investigated the value of total and differential leukocyte counts in assessing long-term prognosis of patients with three-vessel disease (TVD), and showed that total WBC count was an independent prognostic element of death and major adverse cardiovascular and cerebrovascular events (MACCEs). Furtherly, lymphocyte-, monocyte-, and eosinophil counts were independent predictive factors of death. Also, monocyte- and eosinophil counts were independent predictors of MACCEs. In addition, the association between novel inflammation-related laboratory parameters and the prognostic value in patients with CAD has garnered widespread interest among researchers. For instance, Hayıroğlu Mİ's team discovered that a newly -Abstract Truncated-
medicine, general & internal